TNFSF10 and glioma: We provided evidence that the TRAIL-resistant U87 and U373 cells revealed the strongest induction of DR5 along with the most pronounced activation of caspases (Fig. 3G–H), supporting the hypothesis that DR5 is an instrumental factor for TRAIL/Olaparib-mediated cell death in high-grade gliomas.